Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.59 USD | +0.22% |
|
-0.22% | -2.34% |
27/06 | Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target | MT |
24/06 | Sophia Genetics S. A. Launches New Residual Acute Myeloid Application | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.34% | 30Cr | |
+20.39% | 3,32200Cr | |
+15.78% | 9.12TCr | |
+13.76% | 8.44TCr | |
+49.30% | 5.64TCr | |
-22.01% | 4.97TCr | |
+35.32% | 4.78TCr | |
-25.51% | 4.6TCr | |
+67.77% | 4.1TCr | |
-4.48% | 2.72TCr |
- Stock Market
- Equities
- SOPH Stock
- News SOPHiA GENETICS SA
- RBC Initiates SOPHiA GENETICS at Outperform With $8 Price Target, Notes 'Attractive' Entry Point, Exposure to Long-Term Growth in Sequencing, Life Science Research